Efficacy and safety of vardenafil in difficult-to-treat erectile dysfunction men.
- Author:
Chuan-hang WANG
1
Author Information
1. Department of Andrology, Beijing Sino-Japan Friendship Hospital, China. sanyitang@sina.com
- Publication Type:Journal Article
- MeSH:
Erectile Dysfunction;
drug therapy;
Humans;
Imidazoles;
therapeutic use;
Male;
Middle Aged;
Phosphodiesterase Inhibitors;
therapeutic use;
Piperazines;
therapeutic use;
Sulfones;
therapeutic use;
Treatment Outcome;
Triazines;
therapeutic use;
Vardenafil Dihydrochloride
- From:
National Journal of Andrology
2006;12(4):377-380
- CountryChina
- Language:Chinese
-
Abstract:
This paper reviewed the efficacy and safety of vardenafil, a highly selective phosphodiesterase type 5 (PDE 5) inhibitor, in men with erectile dysfunction who were difficult to treat. Several large-scale studies indicated vardenafil was effective and safe in the treatment of these difficult-to-treat ED patients, including ED with depression or diabetes, ED after radical retropubic prostatectomy, ED caused by spinal cord injury, and sildenafil nonresponders. Vardenafil provides a rational treatment alternative.
